KNTV NBC Nightly News With Lester Holt June 4, 2024 23:27:00
Fefeel significant symymptom rerelief with h skyrizi, including g less abdomominal pn and fewewer bowel movementnts at 4 weeeeks. skyryrizi is thehe first anand only il-l-23 inhibitir for crohn'n's that c can delir both clilinical remimission and endodoscopic impmprovemen. ththe majorityty of pepeople on skskyrizi achieved l long lastining remimission at 1 1 year. serious alallergic reaeactios anand an increreased ririsk of infefections or a a lower abibility to fight ththem may occccur. tellll your doctctor if you ue anan infectionon or symptoto, had d a vaccine e or plan to. liver proboblems...